Literature DB >> 27320019

High-density mammalian cell cultures in stirred-tank bioreactor without external pH control.

Sen Xu1, Hao Chen2.   

Abstract

Maintaining desired pH is a necessity for optimal cell growth and protein production. It is typically achieved through a two-sided pH control loop on the bioreactor controller. Here we investigated cell culture processes with minimum or no pH control and demonstrated that high-density mammalian cell cultures could be maintained for long-term protein production without pH control. The intrinsic interactions between pCO2, lactate, and pH were leveraged to maintain culture pH. Fed-batch cultures at the same lower pH limit of 6.75 but different upper pH limits (7.05, 7.30, 7.45, 7.65) were evaluated in the 3L bioreactors and comparable results were obtained. Neither CO2 sparging nor base addition was required to control pH in the pH range of 6.75-7.65. The impact of sparger configurations (drilled hole sparger vs. frit sparger) and scales (3L vs. 200L) on CO2 accumulation and culture pH was also demonstrated. The same principle was applied in two perfusion cultures with steady state cell densities at 42.5±3.3 or 68.3±6.0×10(6)cells/mL with low cell specific perfusion rates (15±2 to 23±3pL/cell/day), achieving up to 1.9±0.1g/L/day bioreactor productivity. Culture pH level in the 3L perfusion bioreactors was steadily maintained by controlling the residual lactate and pCO2 levels without the requirement of external pH control for up to 40days with consistent productivity and product quality. Furthermore, culture pH could be potentially modulated via adjusting residual glucose levels and CO2 stripping capability in perfusion cultures. To the best of our knowledge, this is the first time a systematic study was performed to evaluate the long-term cell cultivation and protein production in stirred-tank bioreactors without external pH control.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CO(2) stripping; Cell metabolism; Fed-batch; Perfusion; Product quality; pH control

Mesh:

Substances:

Year:  2016        PMID: 27320019     DOI: 10.1016/j.jbiotec.2016.06.019

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  8 in total

1.  Process intensification in fed-batch production bioreactors using non-perfusion seed cultures.

Authors:  Andrew Yongky; Jianlin Xu; Jun Tian; Christopher Oliveira; Jia Zhao; Kevin McFarland; Michael C Borys; Zheng Jian Li
Journal:  MAbs       Date:  2019-08-19       Impact factor: 5.857

2.  Engineering death resistance in CHO cells for improved perfusion culture.

Authors:  Michael A MacDonald; Matthias Nöbel; Verónica S Martínez; Kym Baker; Evan Shave; Peter P Gray; Stephen Mahler; Trent Munro; Lars K Nielsen; Esteban Marcellin
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

3.  Designing a Strategy for pH Control to Improve CHO Cell Productivity in Bioreactor.

Authors:  Zohreh Ahleboot; Mahdi Khorshidtalab; Paria Motahari; Rasoul Mahboudi; Razieh Arjmand; Aram Mokarizadeh; Shayan Maleknia
Journal:  Avicenna J Med Biotechnol       Date:  2021 Jul-Sep

4.  Stress-induced increase of monoclonal antibody production in CHO cells.

Authors:  Jana Schellenberg; Tamanna Nagraik; Ole Jacob Wohlenberg; Sebastian Ruhl; Janina Bahnemann; Thomas Scheper; Dörte Solle
Journal:  Eng Life Sci       Date:  2022-02-24       Impact factor: 3.405

Review 5.  Bioengineering Outlook on Cultivated Meat Production.

Authors:  Ivana Pajčin; Teodora Knežić; Ivana Savic Azoulay; Vanja Vlajkov; Mila Djisalov; Ljiljana Janjušević; Jovana Grahovac; Ivana Gadjanski
Journal:  Micromachines (Basel)       Date:  2022-02-28       Impact factor: 2.891

6.  A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.

Authors:  Sabrina Janoschek; Markus Schulze; Gerben Zijlstra; Gerhard Greller; Jens Matuszczyk
Journal:  Biotechnol Prog       Date:  2018-12-19

7.  Rapid development of clone-specific, high-performing perfusion media from established feed supplements.

Authors:  Patrick Mayrhofer; David Reinhart; Andreas Castan; Renate Kunert
Journal:  Biotechnol Prog       Date:  2019-11-11

Review 8.  Microcarriers in application for cartilage tissue engineering: Recent progress and challenges.

Authors:  Sheng-Long Ding; Xin Liu; Xi-Yuan Zhao; Ke-Tao Wang; Wei Xiong; Zi-Li Gao; Cheng-Yi Sun; Min-Xuan Jia; Cheng Li; Qi Gu; Ming-Zhu Zhang
Journal:  Bioact Mater       Date:  2022-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.